Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R Mann

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Biochimica Et Biophysica Acta|September 27, 2000
Diverse mechanisms of inhibition of pyruvate dehydrogenase kinase by structurally distinct inhibitorsW R Mann, C J Dragland, C C Vinluan, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Triterpene and diterpene inhibitors of pyruvate dehydrogenase kinase (PDK)T D Aicher, R E Damon, J Koletar, et al.
Genomics|February 1, 1991
Fanconi anemia: evidence for linkage heterogeneity on chromosome 20qW R Mann, V S Venkatraj, R G Allen, et al.
Journal of Medicinal Chemistry|September 1, 1995
Antidiabetic agents: a new class of reversible carnitine palmitoyltransferase I inhibitorsR C Anderson, M Balestra, P A Bell, et al.
The Biochemical Journal|September 8, 1998
Heterologously expressed inner lipoyl domain of dihydrolipoyl acetyltransferase inhibits ATP-dependent inactivation of pyruvate dehydrogenase complex. Identification of important amino acid residuesJ C Jackson, C C Vinluan, C J Dragland, et al.
Journal of Medicinal Chemistry|June 8, 2000
Anilides of (R)-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinaseG R Bebernitz, T D Aicher, J L Stanton, et al.
Journal of Medicinal Chemistry|January 29, 2000
Secondary amides of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinaseT D Aicher, R C Anderson, J Gao, et al.
Journal of Medicinal Chemistry|July 30, 1999
(R)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionamides are orally active inhibitors of pyruvate dehydrogenase kinaseT D Aicher, R C Anderson, G R Bebernitz, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Biochimica Et Biophysica Acta|September 27, 2000
Diverse mechanisms of inhibition of pyruvate dehydrogenase kinase by structurally distinct inhibitorsW R Mann, C J Dragland, C C Vinluan, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Triterpene and diterpene inhibitors of pyruvate dehydrogenase kinase (PDK)T D Aicher, R E Damon, J Koletar, et al.
Genomics|February 1, 1991
Fanconi anemia: evidence for linkage heterogeneity on chromosome 20qW R Mann, V S Venkatraj, R G Allen, et al.
Journal of Medicinal Chemistry|September 1, 1995
Antidiabetic agents: a new class of reversible carnitine palmitoyltransferase I inhibitorsR C Anderson, M Balestra, P A Bell, et al.
The Biochemical Journal|September 8, 1998
Heterologously expressed inner lipoyl domain of dihydrolipoyl acetyltransferase inhibits ATP-dependent inactivation of pyruvate dehydrogenase complex. Identification of important amino acid residuesJ C Jackson, C C Vinluan, C J Dragland, et al.
Journal of Medicinal Chemistry|June 8, 2000
Anilides of (R)-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinaseG R Bebernitz, T D Aicher, J L Stanton, et al.
Journal of Medicinal Chemistry|January 29, 2000
Secondary amides of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinaseT D Aicher, R C Anderson, J Gao, et al.
Journal of Medicinal Chemistry|July 30, 1999
(R)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionamides are orally active inhibitors of pyruvate dehydrogenase kinaseT D Aicher, R C Anderson, G R Bebernitz, et al.
Pageof 2